Alarm grew after a researcher resigned, warning that the “people building AI earnestly believe that it could kill us all by ...

The latest from Paul Schrader, the Dardenne brothers, and Hirokazu Kore-eda stud our latest dispatch from the fest.

A researcher at Anthropic, the company behind the AI chatbot Claude, has quit over fears that the technology will ‘kill us ...

Researcher believes overprivileged Iterable creds exposed 8.8M customer records – and could have enabled mass deletion ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Recursion is one of those ideas developers learn early and trust for years. If the recursive step is simple and the base case is correct, the code feels clean and safe. It is elegant for a reason: ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive risks persist and the company is years away from meaningful pipeline revenue. RXRX's AI-driven Recursion OS platform shows strong ...

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...